[1]
L. Figueroa-Valverde, M. Rosas-Nexticapa, M. Alvarez-Ramirez, M. V. Mateu-Armad, and R. Cauich-Carrillo, “Theoretical interaction of muscarinic receptor antagonist with vascular endothelial growth factor receptors (VEGF-R1, R2 and R3) as a therapeutic alternative to treat cancer”, Braz. J. of Sci., vol. 4, no. 5, pp. 1–14, Apr. 2025.